LKFT
Lakefront Biotherapeutics NV
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Neutral
-5/100
Last price
29.32
▼ 0.19 (0.64%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
29.95
Prev close
29.51
Day high
29.90
Day low
29.09
Volume
452.12K
Market cap
$1.92B
P/E (TTM)
2.79
52W range
25.68 – 36.24
Day trading desk
Gap from prior close
+1.49%
Prior close 29.51
VWAP
29.43
-0.37% from price
Relative volume
3.34×
Unusually busy
Session range
2.96%
29.09 – 29.95
Position in range
27%
Near session low
ATR (14D)
0.95
3.24% of price
Prior day high
29.91
PDH
Prior day low
29.24
PDL
Bid / ask spread
—
Quote not published
Session volume
870.10K
Avg 260.15K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.68%
-2.6%
1M
+2.91%
+1.8%
3M
-4.84%
-9.4%
6M
+1.35%
-16.8%
YTD
-10.34%
-24.6%
1Y
-22.06%
-38.5%
3Y
-15.14%
-97.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
11 more panels on LKFT open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
334.15M
Total on file
Fundamentals
Market cap$1.92B
Enterprise value$36.27B
Revenue (TTM)$990.57M
Gross profit$669.75M
EBITDA$568.92M
Net income$594.32M
EPS (TTM)$10.52
Free cash flow$138.21M
Total cash$2.24B
Total debt$6.36M
Book value / share$2.82
Shares outstanding65.48M
Float474.38M
Short % of float8.52%
Dividend yield0.00%
Beta (5Y)0.06
Valuation & profitability ratios
Trailing P/E2.79
Forward P/E-24.58
PEG ratio—
Price / sales—
Price / book10.41
EV / revenue36.61
EV / EBITDA63.75
Gross margin67.61%
Operating margin-359.30%
Profit margin60.23%
Return on equity20.12%
Return on assets9.93%
Debt / equity0.20
Current ratio32.84
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.11B | $275.65M | $239.72M | $241.25M | +303.5% |
| Operating revenue | $1.11B | $275.65M | $239.72M | $241.25M | +303.5% |
| Cost of revenue | $29.74M | $34.86M | $0 | $0 | -14.7% |
| Gross profit | $1.08B | $240.79M | $239.72M | $241.25M | +349.6% |
| Research & development | $459.42M | $335.46M | $241.29M | $269.80M | +37.0% |
| Selling, general & admin | $111.96M | $96.88M | $94.25M | $103.31M | +15.6% |
| Total operating expense | $581.12M | $429.12M | $327.99M | $372.31M | +35.4% |
| Operating income | $501.39M | -$188.34M | -$88.26M | -$131.06M | +366.2% |
| Net interest income | $45.19M | $89.46M | $77.64M | $8.71M | -49.5% |
| Pre-tax income | $300.87M | -$3.08M | $5.63M | -$70.85M | +9,852.7% |
| Tax provision | -$18.62M | -$1.80M | $9.61M | $572.00K | -932.8% |
| Net income | $320.88M | $74.08M | $211.70M | -$217.99M | +333.1% |
| Net income to common | $320.88M | $74.08M | $211.70M | -$217.99M | +333.1% |
| Basic EPS | 4.87 | 1.12 | 3.21 | -3.32 | +334.8% |
| Diluted EPS | 4.87 | 1.12 | 3.21 | -3.32 | +334.8% |
| EBIT | $303.09M | -$2.17M | $7.39M | -$61.69M | +14,041.5% |
| EBITDA | $358.96M | $43.33M | $51.04M | $3.87M | +728.5% |
| Basic shares | 65.90M | 66.14M | 65.88M | 65.66M | -0.4% |
| Diluted shares | 65.90M | 66.14M | 65.88M | 65.66M | -0.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $87.87M | $64.24M | $166.80M | $508.12M | +36.8% |
| Cash & short-term investments | $3.00B | $3.12B | $3.68B | $4.09B | -3.8% |
| Accounts receivable | $9.57M | $32.47M | $17.49M | $28.19M | -70.5% |
| Inventory | $22.49M | $51.19M | $73.98M | $52.92M | -56.1% |
| Total current assets | $3.08B | $3.34B | $3.86B | $4.24B | -7.8% |
| Property, plant & equipment | $80.66M | $122.90M | $126.32M | $154.25M | -34.4% |
| Goodwill & intangibles | $848.00K | $234.87M | $197.46M | $216.17M | -99.6% |
| Total assets | $3.41B | $4.14B | $4.36B | $4.73B | -17.6% |
| Total current liabilities | $152.86M | $335.08M | $428.22M | $522.54M | -54.4% |
| Total debt | $6.92M | $11.72M | $9.60M | $21.90M | -41.0% |
| Total liabilities | $170.65M | $1.24B | $1.56B | $2.21B | -86.2% |
| Retained earnings | $210.58M | -$134.31M | -$228.27M | -$496.69M | +256.8% |
| Shareholder equity | $3.24B | $2.90B | $2.80B | $2.53B | +11.7% |
| Working capital | $2.93B | $3.00B | $3.43B | $3.71B | -2.6% |
| Net tangible assets | $3.24B | $2.66B | $2.60B | $2.31B | +21.5% |
| Shares issued | 65.90M | 65.90M | 65.90M | 65.84M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $320.88M | $74.08M | $211.70M | -$217.99M | +333.1% |
| Depreciation & amortisation | $55.88M | $45.50M | $43.64M | $65.57M | +22.8% |
| Stock-based compensation | $24.00M | $19.89M | $56.72M | $88.51M | +20.7% |
| Change in working capital | -$876.57M | -$320.55M | -$692.43M | -$379.47M | -173.5% |
| Operating cash flow | -$257.46M | -$320.03M | -$405.97M | -$500.54M | +19.6% |
| Capital expenditure | -$13.86M | -$82.11M | -$19.27M | -$36.95M | +83.1% |
| Investing cash flow | $288.81M | $220.60M | $71.19M | -$1.25B | +30.9% |
| Financing cash flow | -$3.27M | -$4.92M | -$5.00M | -$1.49M | +33.5% |
| Free cash flow | -$271.31M | -$402.14M | -$425.24M | -$537.49M | +32.5% |
| End cash position | $87.87M | $64.24M | $166.81M | $508.12M | +36.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $12.11M | $6.48M | $900.82M | $71.16M | $65.29M | — | +86.9% |
| Operating revenue | $12.11M | $6.48M | $900.82M | $71.16M | $65.29M | — | +86.9% |
| Cost of revenue | $9.14M | $4.80M | $455.00K | $10.85M | $4.71M | — | +90.6% |
| Gross profit | $2.96M | $1.68M | $900.37M | $60.31M | $60.58M | — | +76.3% |
| Research & development | $25.52M | $30.96M | $107.51M | $73.88M | $95.28M | — | -17.6% |
| Selling, general & admin | $7.51M | $35.51M | $2.94M | $46.42M | $18.80M | — | -78.9% |
| Total operating expense | $46.48M | $65.39M | $141.57M | $101.99M | $117.61M | — | -28.9% |
| Operating income | -$43.51M | -$63.70M | $758.80M | -$41.67M | -$57.03M | — | +31.7% |
| Net interest income | $12.65M | $13.42M | $14.75M | $9.27M | $9.39M | — | -5.7% |
| Pre-tax income | $2.01M | $13.96M | $783.15M | -$221.49M | -$104.42M | — | -85.6% |
| Tax provision | $70.00K | $70.00K | $666.00K | -$17.50M | $26.00K | — | 0.0% |
| Net income | $2.11M | $14.49M | $782.15M | -$202.11M | -$105.75M | — | -85.4% |
| Net income to common | $2.11M | $14.49M | $782.15M | -$202.11M | -$105.75M | — | -85.4% |
| Basic EPS | — | 0.22 | — | — | — | -2.33 | — |
| Diluted EPS | — | 0.22 | — | — | — | -2.33 | — |
| EBIT | $79.80M | -$63.70M | $560.50M | $2.42M | -$101.12M | — | +225.3% |
| EBITDA | $79.80M | -$63.70M | $560.50M | $2.42M | -$101.12M | — | +225.3% |
| Basic shares | — | 65.87M | — | — | — | 65.84M | — |
| Diluted shares | — | 65.87M | — | — | — | 65.84M | — |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $135.95M | $66.81M | $87.87M | $64.46M | $71.67M | +103.5% |
| Cash & short-term investments | $2.24B | $2.98B | $3.00B | $3.05B | $3.09B | -24.9% |
| Accounts receivable | $23.70M | $21.74M | $9.57M | $45.33M | $55.50M | +9.0% |
| Inventory | $8.54M | $17.69M | $22.49M | $22.95M | $33.79M | -51.7% |
| Total current assets | $2.31B | $3.06B | $3.08B | $3.16B | $3.26B | -24.5% |
| Property, plant & equipment | $76.89M | $76.95M | $80.66M | $105.62M | $109.69M | -0.1% |
| Goodwill & intangibles | $750.66M | $746.00K | $848.00K | $7.42M | $216.58M | +100,524.5% |
| Total assets | $3.35B | $3.37B | $3.41B | $3.51B | $3.82B | -0.6% |
| Total current liabilities | $70.32M | $100.42M | $152.86M | $366.56M | $402.95M | -30.0% |
| Total debt | $6.36M | $6.43M | $6.92M | $7.50M | $8.44M | -1.1% |
| Total liabilities | $87.56M | $119.06M | $170.65M | $1.06B | $1.17B | -26.5% |
| Retained earnings | $233.96M | $228.33M | $210.58M | -$577.74M | -$380.80M | +2.5% |
| Shareholder equity | $3.26B | $3.25B | $3.24B | $2.45B | $2.64B | +0.3% |
| Working capital | $2.24B | $2.96B | $2.93B | $2.80B | $2.85B | -24.4% |
| Net tangible assets | $2.51B | $3.25B | $3.24B | $2.44B | $2.43B | -22.7% |
| Shares issued | 65.85M | 65.90M | 65.90M | 65.90M | 65.90M | -0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $2.11M | $14.49M | $782.15M | -$202.11M | -$105.75M | -85.4% |
| Change in working capital | -$7.52M | -$35.44M | -$813.79M | -$57.83M | -$57.21M | +78.8% |
| Operating cash flow | -$34.09M | -$82.75M | -$47.46M | -$62.61M | -$108.78M | +58.8% |
| Capital expenditure | -$29.00K | -$123.00K | -$1.60M | -$2.85M | -$4.16M | +76.4% |
| Investing cash flow | $101.42M | $61.50M | $72.62M | $56.74M | $74.71M | +64.9% |
| Financing cash flow | -$3.94M | -$510.00K | -$405.00K | -$1.26M | -$600.00K | -672.2% |
| Free cash flow | -$34.12M | -$82.87M | -$49.06M | -$65.46M | -$112.94M | +58.8% |
| End cash position | $135.95M | $66.81M | $87.87M | $64.46M | $71.67M | +103.5% |
Options analytics
Put / call volume
1.00
Call-heavy session
Put / call open interest
0.25
Positioning, not flow
Max pain
30.00
+2.3% from spot
ATM implied vol
142.1%
Nearest strike to spot
Skew (10% OTM)
-168.3%
Calls bid over puts
Call volume
3
Contracts, this expiry
Put volume
3
Contracts, this expiry
Heaviest call OI
32.50
7 contracts
Heaviest put OI
30.00
4 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -11.50 | 0.03 | +100.3% |
| Mar 2026 | -0.97 | 0.21 | +121.6% |
| Dec 2025 | -0.07 | 12.27 | +17,634.6% |
| Sep 2025 | -0.28 | -0.18 | +37.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.23 | 1 | $41.18M | -42.1% |
| Next quarter | -0.17 | 2 | $106.78M | -88.1% |
| Current year | -0.71 | 1 | $117.22M | -89.5% |
| Next year | -1.06 | 2 | $84.62M | -27.8% |
Analyst targets & ownership
Mean target$30.26
High target$44.17
Low target$21.34
Implied upside3.21%
Analyst count3
ConsensusHOLD
Strong buy / Buy1 / 1
Hold3
Sell / Strong sell1 / 0
Held by insiders25.45%
Held by institutions23.63%
Institutions holding99
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
29.65
-1.12% from price
SMA 20
28.85
+1.63% from price
SMA 50
28.37
+3.36% from price
SMA 100
28.53
+2.79% from price
SMA 200
30.12
-2.66% from price
EMA 12
29.32
-0.01% from price
EMA 26
29.02
+1.05% from price
EMA 50
28.80
+1.82% from price
RSI (14)
52.6
Neutral
MACD (12,26,9)
0.31
Hist -0.01
ATR (14)
0.95
3.24% of price
Realised vol 30D
32.9%
Annualised
Bollinger upper
31.26
20, 2σ
Bollinger lower
26.44
20, 2σ
50 / 200 cross
Death
28.37 vs 30.12
Trend bias
Below 200
-2.66%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.58
Less volatile than market
Correlation to SPY
0.26
Largely independent
Realised vol 30D
32.9%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-26.6%
Peak to trough
Max drawdown 5Y
-68.3%
Peak to trough
ATR 14
0.95
3.24% of price
Beta (reported)
0.06
5Y monthly, from filing
Short interest
Shares short
3.41M
Prior 2.97M
Change vs prior
+14.8%
Shorts adding
% of float
8.52%
Normal
% of shares out
5.21%
Against total outstanding
Days to cover
13.1
Crowded exit
Float
474.38M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 23, 26 | RBC Capital | UPGRADE | Sector Perform | Outperform |
| Aug 11, 26 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Aug 11, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Feb 25, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
6-K · 2026-09-29
Corporate Changes & Voting Matters
6-K · 2026-09-23
Corporate Changes & Voting Matters
6-K · 2026-09-15
Corporate Changes & Voting Matters
6-K · 2026-09-08
Corporate Changes & Voting Matters
6-K · 2026-09-01
Corporate Changes & Voting Matters
6-K · 2026-08-25
Corporate Changes & Voting Matters
6-K · 2026-08-18
Corporate Changes & Voting Matters
6-K · 2026-08-12
Headlines
Acquisition of Own Shares
GlobeNewswire · 10h ago
Acquisition of Own Shares
GlobeNewswire · 7d ago
Lakefront Biotherapeutics' Gamgertamig Has Meaningful Opportunity in Rare Autoimmune Diseases, RBC Says
MT Newswires · 14d ago
RBC Upgrades Lakefront Biotherapeutics to Outperform From Sector Perform, Adds Speculative Risk, Raises Price Target to $45 From $26
MT Newswires · 14d ago
Acquisition of Own Shares
GlobeNewswire · 14d ago
Lakefront Biotherapeutics Targets 2027 Registrational Trials for Gamgertamig
MarketBeat · 16d ago
Acquisition of Own Shares
GlobeNewswire · 21d ago
Acquisition of Own Shares
GlobeNewswire · 28d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.